Insightec said today it won Medicare benefit coverage from CGS Medicare and Palmetto GBA for procedures using its Neuravive MR-guided focused ultrasound system to treat essential tremor.
The Israel-based company said that with the addition, 25 states now cover its Neuravive treatment for medication-refractory essential tremor.
“2018 marks the year of Medicare reimbursement for incisionless focused ultrasound treatment for essential tremor. We’re excited by this momentum and look forward to coverage for all Medicare patients in the U.S. in the near future,” board chair and CEO Dr. Maurice Ferré said in a press release.
“Focused ultrasound offers medication-refractory essential tremor patients tremor improvement with no incisions and minimal complications,” Dr. Vibhor Krishna of The Ohio State University Wexner Medical Center said in a press release.
Last week, Insightec said that it won expanded FDA approval for its Exablate Neuro, which is now cleared as compatible with a number of Siemens (NYSE:SI) Healthineer’s magnetic resonance imaging scanners.